Clinical trial
Evaluation of the TR(ACE) Assay for the Ability to Aid in Monitoring Disease Progress, Response to Therapy or for Recurrent or Residual Disease for Patients With Previously Diagnosed Cancers (Stage III and IV Lung and Stage IV Breast)
NCT02934360 is registered in ClinicalTrials.gov with Biological Dynamics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the TR(ACE) Assay for the Ability to Aid in Monitoring Disease Progress, Response to Therapy or for Recurrent or Residual Disease for Patients With Previously Diagnosed Cancers (Stage III and IV Lung and Stage IV Breast)
- Lead sponsor
- Biological Dynamics
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2016
- Completion date
- April 30, 2018
- Enrollment
- 450 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.